Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Regeneron Pharmaceuticals, Inc. (REGN) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Regeneron Pharmaceuticals, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 872589.
Total stock buying since 2005: $2,475,753,844.
Total stock sales since 2005: $14,586,084,237.
Total stock option exercises since 2005: $1,313,104,322.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 210,364 | $207,522,474 | 616,322 | $254,112,622 |
| 2023 | 0 | $0 | 95,808 | $78,349,729 | 273,334 | $75,352,970 |
| 2022 | 0 | $0 | 209,705 | $142,182,035 | 469,330 | $145,352,340 |
| 2021 | 0 | $0 | 563,365 | $351,623,746 | 2,003,096 | $333,732,044 |
| 2020 | 0 | $0 | 24,311,062 | $12,445,396,750 | 1,955,372 | $164,839,706 |
| 2019 | 0 | $0 | 416,206 | $143,310,975 | 917,671 | $23,311,139 |
| 2018 | 0 | $0 | 427,003 | $148,810,340 | 927,576 | $18,552,974 |
| 2017 | 462,141 | $212,021,764 | 137,384 | $65,407,790 | 900,886 | $27,301,249 |
| 2016 | 148,669 | $62,482,433 | 20,663 | $8,394,544 | 774,368 | $17,691,794 |
| 2015 | 260,466 | $131,463,987 | 420,930 | $219,457,542 | 678,280 | $37,168,578 |
| 2014 | 6,498,829 | $2,040,580,495 | 592,551 | $211,494,397 | 1,689,378 | $74,072,416 |
| 2013 | 0 | $0 | 979,452 | $254,768,275 | 1,464,593 | $33,265,521 |
| 2012 | 0 | $0 | 1,215,019 | $159,380,088 | 2,319,093 | $46,475,631 |
| 2011 | 0 | $0 | 729,476 | $37,856,945 | 1,678,597 | $36,895,258 |
| 2010 | 1,034,901 | $28,971,078 | 317,918 | $9,118,977 | 332,278 | $5,014,862 |
| 2009 | 12,500 | $234,087 | 114,271 | $2,249,950 | 651,002 | $5,760,483 |
| 2008 | 0 | $0 | 156,479 | $3,272,738 | 500,195 | $4,022,051 |
| 2007 | 0 | $0 | 224,867 | $5,157,435 | 316,441 | $3,033,949 |
| 2006 | 0 | $0 | 443,650 | $8,648,660 | 580,125 | $5,427,485 |
| 2005 | 0 | $0 | 7,562,667 | $83,680,847 | 135,000 | $1,721,250 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-07-25 | Powchik Peter (SVP Clinical Development) | Option Ex | 25,000 | 15.64 | 391,000 |
| 2011-07-14 | Roberts William (VP Regulatory Development and) | Sale | 110 | 56.75 | 6,242 |
| 2011-07-14 | Vagelos P Roy (Chairman of the Board) | Sale | 658 | 56.75 | 37,341 |
| 2011-07-13 | Roberts William (VP Regulatory Development and) | Sale | 4,322 | 57.09 | 246,742 |
| 2011-07-13 | Vagelos P Roy (Chairman of the Board) | Sale | 25,935 | 57.09 | 1,480,629 |
| 2011-07-12 | Roberts William (VP Regulatory Development and) | Sale | 3,939 | 57.11 | 224,956 |
| 2011-07-12 | Vagelos P Roy (Chairman of the Board) | Sale | 23,635 | 57.12 | 1,350,031 |
| 2011-07-11 | Roberts William (VP Regulatory Development and) | Sale | 4,129 | 58.30 | 240,733 |
| 2011-07-11 | Vagelos P Roy (Chairman of the Board) | Sale | 24,772 | 58.30 | 1,444,281 |
| 2011-07-01 | Goldstein Joseph L (Director) | Sale | 10,000 | 56.16 | 561,550 |
| 2011-07-01 | Goldstein Joseph L (Director) | Option Ex | 10,000 | 28.81 | 288,100 |
| 2011-07-01 | Baker Charles A (Director) | Sale | 11,000 | 56.63 | 622,963 |
| 2011-07-01 | Baker Charles A (Director) | Option Ex | 11,000 | 28.81 | 316,910 |
| 2011-07-01 | Brown Michael S (Director) | Sale | 25,000 | 56.19 | 1,404,825 |
| 2011-07-01 | Brown Michael S (Director) | Option Ex | 25,000 | 24.47 | 611,825 |
| 2011-05-04 | Goldstein Joseph L (Director) | Sale | 5,000 | 48.89 | 244,450 |
| 2011-05-04 | Goldstein Joseph L (Director) | Option Ex | 5,000 | 28.81 | 144,050 |
| 2011-05-02 | Gilman Alfred G (Director) | Sale | 20,000 | 50.90 | 1,017,900 |
| 2011-04-18 | Brown Michael S (Director) | Sale | 5,000 | 49.00 | 245,000 |
| 2011-04-05 | Stahl Neil (SVP Res and Dev Sciences) | Sale | 34,115 | 46.03 | 1,570,313 |
| 2011-04-04 | Stahl Neil (SVP Res and Dev Sciences) | Option Ex | 92,308 | 13.00 | 1,200,004 |
| 2011-03-31 | Brown Michael S (Director) | Sale | 3,309 | 44.65 | 147,746 |
| 2011-03-30 | Stahl Neil (SVP Res and Dev Sciences) | Sale | 7,692 | 45.00 | 346,140 |
| 2011-03-30 | Stahl Neil (SVP Res and Dev Sciences) | Option Ex | 7,692 | 13.00 | 99,996 |
| 2011-03-30 | Brown Michael S (Director) | Option Ex | 5,000 | 15.01 | 75,050 |
| 2011-03-21 | Mccorkle Douglas S (VP Controller and Asst Treasur) | Sale | 10,600 | 40.02 | 424,212 |
| 2011-03-21 | Mccorkle Douglas S (VP Controller and Asst Treasur) | Option Ex | 10,600 | 20.32 | 215,392 |
| 2011-03-21 | Goldstein Joseph L (Director) | Sale | 11,505 | 40.00 | 460,200 |
| 2011-03-17 | Gilman Alfred G (Director) | Sale | 1,700 | 38.97 | 66,249 |
| 2011-03-17 | Gilman Alfred G (Director) | Option Ex | 30,000 | 23.80 | 714,150 |
| 2011-03-10 | Brown Michael S (Director) | Sale | 3,094 | 39.09 | 120,944 |
| 2011-03-09 | Mccorkle Douglas S (VP Controller and Asst Treasur) | Sale | 9,400 | 40.00 | 376,000 |
| 2011-03-09 | Mccorkle Douglas S (VP Controller and Asst Treasur) | Option Ex | 9,400 | 20.32 | 191,008 |
| 2011-03-09 | Goldstein Joseph L (Director) | Option Ex | 15,000 | 9.17 | 137,550 |
| 2011-03-09 | Shooter Eric M (Director) | Sale | 27,500 | 40.00 | 1,100,000 |
| 2011-03-09 | Shooter Eric M (Director) | Option Ex | 27,500 | 23.75 | 653,207 |
| 2011-03-09 | Brown Michael S (Director) | Sale | 5,000 | 40.00 | 200,000 |
| 2011-03-09 | Brown Michael S (Director) | Option Ex | 5,000 | 15.01 | 75,050 |
| 2011-03-04 | Terifay Robert J (SVP Commercial) | Sale | 6,099 | 38.00 | 231,762 |
| 2011-03-04 | Terifay Robert J (SVP Commercial) | Option Ex | 6,099 | 21.92 | 133,690 |
| 2011-02-18 | Goldberg Murray A (SVP F&A, CFO, Treas & Asst Sec) | Sale | 4,569 | 37.08 | 169,418 |
| 2011-02-17 | Terifay Robert J (SVP Commercial) | Sale | 48,901 | 38.00 | 1,858,238 |
| 2011-02-17 | Terifay Robert J (SVP Commercial) | Option Ex | 48,901 | 21.53 | 1,052,985 |
| 2011-02-17 | Goldberg Murray A (SVP F&A, CFO, Treas & Asst Sec) | Option Ex | 14,850 | 19.43 | 288,535 |
| 2011-02-14 | Terifay Robert J (SVP Commercial) | Sale | 5,000 | 37.02 | 185,100 |
| 2011-02-14 | Terifay Robert J (SVP Commercial) | Option Ex | 5,000 | 21.34 | 106,700 |
| 2011-02-11 | Goldstein Joseph L (Director) | Sale | 2,761 | 36.66 | 101,218 |
| 2011-02-10 | Goldstein Joseph L (Director) | Option Ex | 5,000 | 15.80 | 79,000 |
| 2011-01-27 | Goldstein Joseph L (Director) | Sale | 5,401 | 34.67 | 187,252 |
| 2011-01-26 | Roberts William (VP Regul Devel & Med Safety) | Sale | 2,693 | 34.49 | 92,881 |
| 2011-01-26 | Goldstein Joseph L (Director) | Option Ex | 10,000 | 15.80 | 158,000 |
| 2011-01-19 | Roberts William (VP Regul Devel & Med Safety) | Sale | 1,399 | 35.02 | 48,985 |
| 2011-01-19 | Brown Michael S (Director) | Sale | 5,155 | 35.59 | 183,492 |
| 2011-01-18 | Van Plew Daniel P (SVP & GM, Indust Ops&Prod Supp) | Sale | 25,000 | 35.22 | 880,500 |
| 2011-01-18 | Van Plew Daniel P (SVP & GM, Indust Ops&Prod Supp) | Option Ex | 25,000 | 21.41 | 535,250 |
| 2011-01-18 | Roberts William (VP Regul Devel & Med Safety) | Sale | 10,000 | 34.99 | 349,900 |
| 2011-01-18 | Roberts William (VP Regul Devel & Med Safety) | Option Ex | 18,812 | 9.49 | 178,525 |
| 2011-01-18 | Shooter Eric M (Director) | Sale | 15,000 | 35.00 | 525,000 |
| 2011-01-18 | Shooter Eric M (Director) | Option Ex | 15,000 | 21.77 | 326,475 |
| 2011-01-18 | Brown Michael S (Director) | Option Ex | 10,000 | 16.91 | 169,050 |
| 2011-01-14 | Roberts William (VP Regul Devel & Med Safety) | Sale | 5,795 | 34.24 | 198,420 |
| 2011-01-14 | Roberts William (VP Regul Devel & Med Safety) | Option Ex | 1,188 | 9.49 | 11,274 |
| 2011-01-07 | Roberts William (VP Regul Devel & Med Safety) | Option Ex | 10,000 | 9.49 | 94,900 |
| 2011-01-07 | Goldberg Murray A (SVP F&A, CFO, Treas & Asst Sec) | Sale | 7,373 | 34.05 | 251,013 |
| 2011-01-06 | Goldberg Murray A (SVP F&A, CFO, Treas & Asst Sec) | Option Ex | 20,000 | 16.21 | 324,300 |
| 2011-01-06 | Vagelos P Roy (Director) | Sale | 21,043 | 34.04 | 716,303 |
| 2011-01-03 | Vagelos P Roy (Director) | Sale | 8,957 | 34.04 | 304,896 |
| 2010-12-23 | Goldberg Murray A (SVP F&A, CFO, Treas & Asst Sec) | Option Ex | 4,000 | 9.49 | 37,960 |
| 2010-12-20 | Brown Michael S (Director) | Sale | 2,103 | 33.06 | 69,535 |
| 2010-12-17 | Goldberg Murray A (SVP F&A, CFO, Treas & Asst Sec) | Sale | 10,336 | 32.15 | 332,302 |
| 2010-12-17 | Goldstein Joseph L (Director) | Sale | 5,281 | 32.00 | 168,992 |
| 2010-12-17 | Brown Michael S (Director) | Option Ex | 5,000 | 18.80 | 94,000 |
| 2010-12-17 | Vagelos P Roy (Director) | Sale | 12,616 | 32.06 | 404,468 |
| 2010-12-16 | Van Plew Daniel P (SVP & GM, Indust Ops&Prod Supp) | Sale | 25,000 | 32.00 | 800,000 |
| 2010-12-16 | Van Plew Daniel P (SVP & GM, Indust Ops&Prod Supp) | Option Ex | 25,000 | 20.90 | 522,499 |
| 2010-12-16 | Goldberg Murray A (SVP F&A, CFO, Treas & Asst Sec) | Option Ex | 32,500 | 13.00 | 422,500 |
| 2010-12-16 | Goldstein Joseph L (Director) | Option Ex | 10,000 | 15.01 | 150,100 |
| 2010-12-16 | Vagelos P Roy (Director) | Sale | 17,384 | 32.04 | 556,983 |
| 2010-11-24 | Goldstein Joseph L (Director) | Sale | 4,331 | 30.06 | 130,189 |
| 2010-11-23 | Goldstein Joseph L (Director) | Option Ex | 10,000 | 16.91 | 169,050 |
| 2010-11-23 | Shooter Eric M (Director) | Sale | 7,500 | 30.00 | 225,000 |
| 2010-11-23 | Shooter Eric M (Director) | Option Ex | 7,500 | 19.69 | 147,675 |
| 2010-11-23 | Vagelos P Roy (Director) | Sale | 30,000 | 30.03 | 900,900 |
| 2010-10-13 | Sanofi-aventis Amerique Du Nord S.n.c. (10% Owner) | Buy | 1,017,401 | 28.00 | 28,487,228 |
| 2010-10-07 | Brown Michael S (Director) | Sale | 1,765 | 28.03 | 49,472 |
| 2010-10-06 | Brown Michael S (Director) | Option Ex | 5,000 | 18.80 | 94,000 |
| 2010-10-04 | Goldstein Joseph L (Director) | Option Ex | 10,000 | 18.80 | 188,000 |
| 2010-06-14 | Ryan Arthur F (Director) | Buy | 10,000 | 26.98 | 269,800 |
| 2010-06-09 | Sing George L (Director) | Option Ex | 5,000 | 25.43 | 127,150 |
| 2010-06-04 | Goldberg Murray A (SVP F&A, CFO, Treas & Asst Sec) | Sale | 6,100 | 28.96 | 176,686 |
| 2010-06-03 | Kolinski Stuart (SVP General Counsel and Secret) | Option Ex | 12,500 | 8.50 | 106,250 |
| 2010-06-03 | Goldberg Murray A (SVP F&A, CFO, Treas & Asst Sec) | Option Ex | 20,000 | 13.00 | 260,000 |
| 2010-06-02 | Baker Charles A (Director) | Option Ex | 5,000 | 25.43 | 127,150 |
| 2010-05-27 | Gilman Alfred G (Director) | Option Ex | 5,000 | 25.43 | 127,150 |
| 2010-05-19 | Brown Michael S (Director) | Sale | 524 | 27.73 | 14,530 |
| 2010-05-18 | Sing George L (Director) | Buy | 7,500 | 28.54 | 214,050 |
| 2010-05-18 | Brown Michael S (Director) | Option Ex | 5,000 | 25.43 | 127,150 |
| 2010-05-17 | Goldstein Joseph L (Director) | Sale | 400 | 28.06 | 11,224 |
| 2010-05-14 | Goldstein Joseph L (Director) | Option Ex | 5,000 | 25.43 | 127,150 |
| 2010-05-14 | Vagelos P Roy (Director) | Sale | 60,000 | 27.07 | 1,624,500 |
| 2010-05-13 | Shooter Eric M (Director) | Option Ex | 5,000 | 25.43 | 127,150 |
| 2010-02-17 | Shooter Eric M (Director) | Sale | 15,000 | 30.00 | 450,000 |
| 2010-02-17 | Shooter Eric M (Director) | Option Ex | 15,000 | 18.80 | 282,000 |
| 2010-02-04 | Roberts William (VP Regul Devel & Med Safety) | Sale | 514 | 27.93 | 14,356 |
| 2010-02-04 | Goldberg Murray A (SVP F&A, CFO, Treas & Asst Sec) | Sale | 6,105 | 27.41 | 167,338 |
| 2010-02-03 | Roberts William (VP Regul Devel & Med Safety) | Sale | 2,329 | 27.87 | 64,909 |
| 2010-02-03 | Roberts William (VP Regul Devel & Med Safety) | Option Ex | 1,500 | 13.00 | 19,500 |
| 2010-02-03 | Kolinski Stuart (SVP General Counsel and Secret) | Sale | 5,401 | 27.87 | 150,525 |
| 2010-02-03 | Goldberg Murray A (SVP F&A, CFO, Treas & Asst Sec) | Option Ex | 20,000 | 11.24 | 224,899 |
| 2010-02-02 | Mccorkle Douglas S (VP Controller and Asst Treasur) | Sale | 5,875 | 28.00 | 164,500 |
| 2010-02-02 | Mccorkle Douglas S (VP Controller and Asst Treasur) | Option Ex | 5,875 | 10.56 | 62,069 |
| 2010-02-02 | Roberts William (VP Regul Devel & Med Safety) | Sale | 5,000 | 27.48 | 137,400 |
| 2010-02-02 | Roberts William (VP Regul Devel & Med Safety) | Option Ex | 12,000 | 13.00 | 156,000 |
| 2010-02-02 | Kolinski Stuart (SVP General Counsel and Secret) | Option Ex | 12,314 | 8.50 | 104,669 |
| 2010-01-28 | Roberts William (VP Regul Devel & Med Safety) | Sale | 2,119 | 26.79 | 56,768 |
| 2010-01-27 | Roberts William (VP Regul Devel & Med Safety) | Option Ex | 6,500 | 13.00 | 84,500 |
| 2010-01-27 | Kolinski Stuart (SVP General Counsel and Secret) | Sale | 4,359 | 27.00 | 117,693 |
| 2010-01-27 | Kolinski Stuart (SVP General Counsel and Secret) | Option Ex | 4,359 | 8.50 | 37,051 |
| 2010-01-21 | Shooter Eric M (Director) | Sale | 15,000 | 26.00 | 390,000 |
| 2010-01-21 | Shooter Eric M (Director) | Option Ex | 15,000 | 15.80 | 237,000 |
| 2010-01-06 | Goldberg Murray A (SVP F&A, CFO, Treas & Asst Sec) | Sale | 12,708 | 24.91 | 316,556 |
| 2010-01-05 | Goldberg Murray A (SVP F&A, CFO, Treas & Asst Sec) | Option Ex | 36,980 | 11.24 | 415,840 |
| 2010-01-05 | Shooter Eric M (Director) | Sale | 15,000 | 25.00 | 375,000 |
| 2010-01-05 | Shooter Eric M (Director) | Option Ex | 15,000 | 15.01 | 225,150 |
| 2009-12-28 | Roberts William (VP Regul Devel & Med Safety) | Sale | 12,500 | 23.99 | 299,875 |
| 2009-12-28 | Roberts William (VP Regul Devel & Med Safety) | Option Ex | 12,500 | 8.50 | 106,250 |
| 2009-12-21 | Mccorkle Douglas S (VP Controller and Asst Treasur) | Sale | 2,456 | 22.00 | 54,032 |
| 2009-12-21 | Mccorkle Douglas S (VP Controller and Asst Treasur) | Option Ex | 2,456 | 8.50 | 20,876 |
| 2009-12-15 | Schleifer Leonard S (CEO and President) | Option Ex | 150,000 | 8.77 | 1,315,500 |
| 2009-12-08 | Vagelos P Roy (Director) | Option Ex | 187,500 | 8.77 | 1,644,375 |
| 2009-12-03 | Yancopoulos George (EVP CSO & Pres Regn Res Labs) | Option Ex | 100,000 | 8.77 | 877,000 |
| 2009-11-13 | Sing George L (Director) | Buy | 12,500 | 18.73 | 234,087 |
| 2009-10-29 | Goldberg Murray A (SVP F&A, CFO, Treas & Asst Sec) | Option Ex | 4,643 | 8.77 | 40,719 |
| 2009-10-27 | Schleifer Leonard S (CEO and President) | Option Ex | 31,611 | 10.44 | 330,018 |
| 2009-09-13 | Schleifer Leonard S (Chief Exec Officer & President) | Sale | 15,900 | 16.55 | 263,176 |
| 2009-09-01 | Roberts William (VP Regul Devel & Med Safety) | Sale | 14,166 | 23.49 | 332,759 |
| 2009-09-01 | Roberts William (VP Regul Devel & Med Safety) | Option Ex | 14,166 | 8.50 | 120,411 |
| 2009-08-12 | Roberts William (VP Regul Devel & Clin Safety) | Sale | 6,666 | 22.99 | 153,251 |
| 2009-08-12 | Roberts William (VP Regul Devel & Clin Safety) | Option Ex | 6,666 | 8.50 | 56,661 |
| 2009-07-27 | Stahl Neil (SVP Res and Dev Sciences) | Sale | 26,886 | 20.88 | 561,379 |
| 2009-07-24 | Stahl Neil (SVP Res and Dev Sciences) | Sale | 10,537 | 20.00 | 210,740 |
| 2009-07-24 | Stahl Neil (SVP Res and Dev Sciences) | Option Ex | 100,000 | 9.49 | 949,000 |
| 2009-04-27 | Roberts William (VP Regul Devel & Clin Safety) | Sale | 15,160 | 12.74 | 193,138 |
| 2009-04-27 | Roberts William (VP Regul Devel & Clin Safety) | Option Ex | 15,160 | 6.50 | 98,540 |
| 2009-02-23 | Brown Michael S (Director) | Option Ex | 5,000 | 7.66 | 38,300 |
| 2009-02-20 | Baker Charles A (Director) | Sale | 10,000 | 18.16 | 181,600 |
| 2009-02-20 | Baker Charles A (Director) | Option Ex | 10,000 | 7.66 | 76,600 |
| 2009-01-21 | Gilman Alfred G (Director) | Option Ex | 10,000 | 7.66 | 76,600 |
| 2009-01-02 | Goldberg Murray A (SVP F&A, CFO, Treas, & Ast Sec) | Option Ex | 1,300 | 7.41 | 9,633 |
| 2008-12-19 | Vagelos P Roy (Director) | Option Ex | 130,000 | 7.41 | 963,300 |
Insider trading activities including stock purchases, stock sales, and option exercises of REGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Regeneron Pharmaceuticals, Inc. (symbol REGN, CIK number 872589) see the Securities and Exchange Commission (SEC) website.